Journal of the National Comprehensive Cancer Network : JNCCN

publication venue for

Metastatic insulinoma: current molecular and cytotoxic therapeutic approaches for metastatic well-differentiated panNETs. 2015
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. 2009
QIM24-186: Surviving and Thriving After Lung Cancer: A Pilot Project to Understand Physician Perspectives on the Approach to Lung Cancer Survivorship Care at Weill Cornell Medicine Medical Oncology.. 22. 2024
Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?. 21. 2023
NCCN Guidelines® Insights: Distress Management, Version 2.2023.. 21. 2023
Immune-Related Adverse Events Among COVID-19-Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade.. 20. 2022
Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based Considerations.. 20. 2022
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma.. 19. 2021
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients.. 18. 2020
Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines.. 18. 2020
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.. 18. 2020
Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy.. 18. 2020
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.. 17. 2019
Geriatric Assessment, Not ASA Physical Status, Is Associated With 6-Month Postoperative Survival in Patients With Cancer Aged ≥75 Years.. 17. 2019
Nonmelanoma Skin Cancer in Childhood and Young Adult Cancer Survivors Previously Treated With Radiotherapy.. 17. 2019
Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers.. 16. 2018
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.. 16. 2018
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.. 16. 2018
Electronic Rapid Fitness Assessment: A Novel Tool for Preoperative Evaluation of the Geriatric Oncology Patient.. 15. 2017
Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.. 14. 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.. 14. 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.. 14. 2016
Anemia and Functional Disability in Older Adults With Cancer.. 13. 2015
Head and Neck Cancers, Version 1.2015.. 13. 2015
Rectal Cancer, Version 2.2015.. 13. 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.. 13. 2015
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer.. 13. 2015
Diet and physical activity in the prevention of colorectal cancer.. 12. 2014
Non-small cell lung cancer, version 1.2015.. 12. 2014
Thyroid carcinoma, version 2.2014.. 12. 2014
Chronic myelogenous leukemia, version 1.2015.. 12. 2014
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.. 12. 2014
Hepatobiliary cancers, version 2.2014.. 12. 2014
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.. 12. 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer.. 12. 2014
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.. 12. 2014
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.. 12. 2014
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .. 12. 2014
Survivorship: introduction and definition. Clinical practice guidelines in oncology.. 12. 2014
Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists.. 11. 2013
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.. 11. 2013
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers.. 11. 2013
Multiple myeloma, version 1.2013.. 11. 2013
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer.. 10. 2012
Ten years of progress in renal cell carcinoma.. 10. 2012
Modern approaches to localized cancer of the esophagus.. 9. 2011
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation.. 9. 2011
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.. 9 Suppl 1. 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.. 9 Suppl 2. 2011
Fertility-sparing surgery in early-stage cervical cancer: indications and applications.. 8. 2010
Geographic proximity and racial disparities in cancer clinical trial participation.. 8. 2010
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis.. 7. 2009
Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.. 2 Suppl 4. 2004
Innovations in the treatment of melanoma.. 2 Suppl 3. 2004
New advances in taxane therapy: the next generation.. 2 Suppl 3. 2004
New advances in the treatment of gastric cancer.. 2 Suppl 3. 2004
Update: NCCN non-small cell lung cancer clinical practice guidelines.. 2 Suppl 3. 2004
Counterpoint: The case against adjuvant high-dose interferon-alpha for melanoma patients.. 2. 2004
Prostate cancer: nomograms and risk assessment models.. 1 Suppl 3. 2003
Update: colorectal cancer guidelines.. 1 Suppl 3. 2003
Psychological issues in geriatric oncology.. 1. 2003
The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions.. 13. 2015
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer.. 11. 2013
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy.. 10. 2012
Hypofractionated whole breast radiation and partial breast radiation for early-stage breast cancers: an update on progress.. 10. 2012
NCCN Task Force Report: Bone Health and Cancer Care. 2006
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer. 2018
Spine Radiosurgery in the Management of Renal Cell Carcinoma Metastases. 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms. 2015
Pertuzumab in the treatment of HER2+ breast cancer. 2014
Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. 2014
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. 2013
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. 2012
Controversies in the management of regional nodes in melanoma. 2012
Novel therapies in phase II and III trials for malignant pleural mesothelioma. 2012
Surgery for early-stage small cell lung cancer. 2011
Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer. 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. 2011
Psychostimulants for cancer-related fatigue. 2010
Non-small cell lung cancer. 2010
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. 2010
NCCN task force report: management of neuropathy in cancer. 2009
NCCN task force report: molecular markers in leukemias and lymphomas. 2009
NCCN task force: clinical utility of PET in a variety of tumor types. 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. 2009
Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach. 2008
NCCN Task Force Report. prevention and management of mucositis in cancer care. 2008
NCCN Task Force Report: breast cancer in the older woman. 2008
Targeted strategies in the treatment of metastatic colon cancer. 2007
Investigational therapies for metastatic thyroid carcinoma. 2007
Invasive breast cancer. 2007
Importance of node dissection in relation to neoadjuvant and adjuvant therapy. 2006
Role of dermatologists in treating melanoma. 2006
Pulmonary neuroendocrine tumors: What (little) do we know? 2006
Favorable early-stage Hodgkin lymphoma. 2006
Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. 2005
Elucidation of the molecular mechanisms of malignant bone tumors: refining diagnosis and identifying novel targets for treatment. 2005
The integration of chemotherapy and surgery for bladder cancer. 2005
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. 2023
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer? 2021
Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma. 2017
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach. 2015
Exocrine pancreas cancer and thromboembolic events: a systematic literature review. 2012
Systemic therapy for advanced pancreatic neuroendocrine tumors: an update. 2012
Late cardiovascular toxicity following chemotherapy for germ cell tumors. 2012
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing? 2009
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. 2017

VIVO Weill Cornell Medical College

Journal of the National Comprehensive Cancer Network : JNCCN Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)